Technology

OpGen

$2.32
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.03 (+1.31%) Today
$0.00 (0.00%) As of 9:42 AM UTC after-hours

Why Robinhood?

You can buy or sell OpGen and other stocks, options, and ETFs commission-free!

About OPGN

OpGen, Inc. Common Stock, also called OpGen, is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It also engages in the development of molecular information products and services for global healthcare settings. It also offers guidance to clinicians about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms (MDROs). The firms products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD. The listed name for OPGN is OpGen, Inc. Common Stock.

CEO
Oliver Schacht
Employees
40
Headquarters
Gaithersburg, Maryland
Founded
2001
Market Cap
44.92M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.90M
High Today
$2.43
Low Today
$2.28
Open Price
$2.31
Volume
1.30M
52 Week High
$5.76
52 Week Low
$1.39

Collections

OPGN Earnings

-$3.95
-$2.63
-$1.32
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 23, After Hours

You May Also Like

NSYS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure